Therapeutic translation of iPSCs for treating neurological disease

Cell Stem Cell. 2013 Jun 6;12(6):678-88. doi: 10.1016/j.stem.2013.05.018.


Somatic cellular reprogramming is a fast-paced and evolving field that is changing the way scientists approach neurological diseases. For the first time in the history of neuroscience, it is feasible to study the behavior of live neurons from patients with neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, and neuropsychiatric diseases, such as autism and schizophrenia. In this Perspective, we will discuss reprogramming technology in the context of its potential use for modeling and treating neurological and psychiatric diseases and will highlight areas of caution and opportunities for improvement.

MeSH terms

  • Humans
  • Nervous System Diseases / pathology
  • Nervous System Diseases / therapy*
  • Pluripotent Stem Cells / cytology*
  • Pluripotent Stem Cells / transplantation*